Robert Sterling

Nessuna posizione attualmente

Health Services

Health Technology

Consumer Services

Profilo

Robert Sterling is Vice President of Business Development for Bioenvision, Inc. Prior to joining Bioenvision in December, 2001, he held various marketing and sales positions at Hoechst Roussel Vet Gmbh.
Mr. Sterling received a BS degree from Pennsylvania State University.

Precedenti posizioni note di Robert Sterling

Società	Posizione	Fine
Hoechst Roussel Vet Gmbh Hoechst Roussel Vet Gmbh Pharmaceuticals: OtherHealth Technology Part of Merck & Co., Inc., Hoechst Roussel Vet Gmbh develops pharmaceutical products for animals. The company is based in Hessen, Germany. Hoechst Roussel Vet was acquired by Intervet International BV from Hoechst AG on August 11, 1999 for $713.99 million.	Corporate Officer/Principal	-
Bioenvision, Inc. Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Robert Sterling

Formazione di Robert Sterling

The Pennsylvania State University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private